June 2011

WEBINAR: “Rapid initiation of ART/ARV during pregnancy” with Elaine Abrams, MD July 28, 2011, 9:00 am ET

Wafaa El-Sadr receives 2011 Global Justice Awards
ICAP Director Wafaa El-Sadr was the recipient of a Health Gap 2011 Global Justice Award. The award honors individuals who have significantly contributed to the growing movement for global health justice. The award was presented to El-Sadr at a ceremony on June 23.

ICAP Hosts Panel at 2011 Global Health Council’s Annual Conference
ICAP hosted a panel at the Global Health Council’s 2011 Annual Conference in Washington, DC on June 16. The panel, “HIV and Non-communicable Diseases: Leveraging HIV Scale-up to Strengthen Chronic Disease Services in Low-Income Countries,” was moderated by ICAP Director Wafaa El-Sadr. Panelists included Dr. Gene Bukhman (Partners in Health), Dr. Miriam Rabkin (ICAP), and Dr. Gloria Sangiwa (Management Sciences for Health).  

WEBINAR RECAP: “New and Innovative Approaches to HIV Therapeutics”
Dr. Shlomo Maayan, director of the Hadassah AIDS Center in Jerusalem, discussed innovative antiretroviral therapies (ART) in clinical practice and provided an update on therapeutic strategies during the ICAP Grand Rounds on June 16.

WEBINAR RECAP: “Methodology Webinar: Using aggregate data for program monitoring and evaluation”
The first ICAP Methodology Webinar on June 22 covered how to develop an evaluation question and concept sheet, how to access and use analysis files for aggregate data, and how to examine trends using aggregate data.

WEBINAR RECAP: “Antiretroviral Treatment for Prevention: Evidence from Recent Studies” Wafaa El-Sadr delivered an ICAP Grand Rounds webinar presentation on June 2 that highlighted what is known about the use of ART for prevention and discussed implications of the findings from the groundbreaking trial, HPTN 052, for confronting the HIV epidemic.

ABOUT ICAP
ICAP was founded in 2004 at Columbia University’s Mailman School of Public Health. Now a global leader in HIV/AIDS services, ICAP has supported work at more than 1,200 sites across 21 countries. More than one million people have received HIV services through ICAP-supported programs.

For more information about ICAP, visit here. For more information about ICAP leadership, visit here.

Supported by Doris Duke Charitable Foundation, Bill and Melinda Gates Foundation, William and Flora Hewlett Foundation, Robert Wood Johnson Foundation, Henry J. Kaiser Family Foundation, Stephen Lewis Foundation, John D. and Catherine T. MacArthur Foundation, National Institutes of Health, David and Lucille Packard Foundation, Rockefeller Foundation, and Starr Foundation.


© 2011 ICAP

Contact US | Unsubscribe

Follow ICAP on Facebook  

DataBytes: HIV-Positive Youth at ICAP-Supported Sites

Download the full issue of DataBytes

Youth between 15 and 24 years of age comprise 45 percent of new HIV infections worldwide. In sub-Saharan Africa alone, nearly 3.3 million youth are estimated to be living with HIV. This group presents unique challenges to those providing HIV services. With initiation of sexual activity and childbearing often occurring between the ages of 15 and 24, youth are particularly at risk of acquiring HIV and possibly transmitting HIV to babies, particularly if their own infection is undiagnosed or untreated. The transition to adulthood is also characterized by high rates of mobility as youth start their own families and seek education and/or employment.  Not surprisingly, research suggests that HIV-infected youth have particular difficulty availing themselves of HIV testing, remaining in care, adhering to treatment, and using prevention practices. Programmatic strategies to address the special needs of youth living with HIV and especially those enrolled in HIV care and treatment are still emerging, and can be informed by data from ICAP-supported programs.

The first issue of DataBytes, a new publication series from ICAP’s Monitoring & Evaluation Unit, uses patient-level data from 123 ICAP-supported HIV care and treatment clinics in Kenya, Mozambique, Rwanda, and Tanzania to examine characteristics of and outcomes among patients aged 15–24. At these ICAP-supported sites, 18,351 youth are currently enrolled in HIV care and 13,012 (71 percent) have initiated antiretroviral therapy (ART). This represents 14 percent and 10 percent of all active patients in care and on ART, respectively. The proportion of youth enrolled at these sites continues to increase, and is almost twice that noted in 2005. At enrollment into care, youth are overwhelmingly female (85 percent), often pregnant (30 percent of females), and mainly referred from PMTCT clinics (30 percent).  While youth are on average healthier than adults when they enroll in HIV care (median CD4 is 399cells/uL vs. 212 cells/uL), they start ART at a similar disease stage to adults (median CD4 is 276cells/uL vs. 199 cells/uL).

 

Figure 1. Number of patients enrolling in HIV care and initiating ART at ICAP-supported clinics by age, sex, and pregnancy status, July–September 2010

New Adolescent HIV Care and Treatment Training Curriculum Released

“Adolescent HIV Care and Treatment: A Training Curriculum for Multidisciplinary Health Care Teams” is a comprehensive training package developed for the Zambian Ministry of Health. The training curriculum builds on the current successes and lessons learned delivering HIV care to adolescents.  It aims to build program and multidisciplinary health care worker capacity to deliver comprehensive, youth-friendly HIV care and treatment services to adolescents living with HIV and their caregivers. This training curriculum includes a Trainer Manual, Participant Manual, and slide sets, and was developed through a collaborative effort between the University Teaching Hospital’s Department of Pediatrics HIV Centre of Excellence in Lusaka, Zambia; ICAP at Columbia University; and the François Xavier Bagnoud (FXB) Center, School of Nursing, University of Medicine and Dentistry of New Jersey. Download the curriculum here.